McKesson to Present at the 38th Annual J.P. Morgan Healthcare Conference: Will Provide Company Overview & Review Updated Fina...
January 13 2020 - 3:10PM
Business Wire
McKesson Corporation (NYSE:MCK) will present at the 38th Annual
J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel
in San Francisco tomorrow, January 14, 2020 at 9:00 AM PT (12:00 PM
ET). Brian Tyler, chief executive officer of McKesson, will provide
a company overview and review topics including:
- McKesson’s strategic growth initiatives
- McKesson’s differentiated specialty portfolio
- Company innovation such as the recent launch of AMP: Access for
More Patients
- Overview of McKesson’s capital allocation approach
- Updated Fiscal 2020 Adjusted Earnings per diluted share
outlook: the company now anticipates Adjusted Earnings per diluted
share of $14.60 to $14.80 for full-year fiscal 2020, an increase
from the previous range of $14.00 to $14.60.
“The focus on executing against our strategic growth initiatives
and disciplined capital allocation is reflected in our updated
outlook for fiscal 2020. Our businesses are well positioned to
continue to deliver growth,” said Brian Tyler, chief executive
officer. “Based on the continued momentum and trends in our
business, we have narrowed and raised our Adjusted EPS guidance
range for fiscal 2020.”
The live audio webcasts for the J.P. Morgan Healthcare
conference will be available on McKesson’s Investor Relations
website at http://investor.mckesson.com. McKesson will host a
conference call at 8:00 AM ET on February 4, 2020 to discuss third
quarter fiscal 2020 financial results. A live audio webcast of the
conference call will be available on McKesson’s Investor Relations
website, along with the company’s earnings press release, financial
tables and slide presentation. The conference call can also be
accessed by dialing 786-815-8297. The password is ‘McKesson’.
Adjusted Earnings
McKesson separately reports financial results on the basis of
Adjusted Earnings. Adjusted Earnings is a non-GAAP financial
measure defined as GAAP income/loss from continuing operations,
excluding amortization of acquisition-related intangible assets,
transaction-related expenses and adjustments, LIFO
inventory-related adjustments, gains from antitrust legal
settlements, restructuring, impairment and related charges, and
other adjustments as well as the related income tax effects for
each of these items, as applicable.
The company does not provide forward-looking guidance on a GAAP
basis prospectively as McKesson is unable to provide a quantitative
reconciliation of this forward-looking non-GAAP measure to the most
directly comparable forward-looking GAAP measure, without
unreasonable effort, because McKesson cannot reliably forecast LIFO
inventory-related adjustments, gains from antitrust legal
settlements, restructuring, impairment and related charges, and
other adjustments, which are difficult to predict and estimate.
These items are inherently uncertain and depend on various factors,
many of which are beyond the company’s control, and as such, any
associated estimate and its impact on GAAP performance could vary
materially.
Cautionary Statements
Except for historical information contained in this press
release, matters discussed may constitute “forward-looking
statements” within the meaning of Section 27A of the Securities Act
of 1933 and Section 21E of the Securities Exchange Act of 1934,
that involve risks and uncertainties that could cause actual
results to differ materially from those in those statements. It is
not possible to identify all such risks and uncertainties. The
reader should not place undue reliance on forward-looking
statements, which speak only as of the date they are first made.
Except to the extent required by law, the company undertakes no
obligation to publicly update forward-looking statements.
Forward-looking statements may be identified by their use of
terminology such as “believes”, “expects”, “anticipates”, “may”,
“will”, “should”, “seeks”, “approximately”, “intends”, “plans”,
“estimates” or the negative of these words or other comparable
terminology. The discussion of financial trends, strategy, plans,
assumptions or intentions may also include forward-looking
statements. We encourage investors to read the important risk
factors described in the company’s Form 10-K, Form 10-Q and Form
8-K reports filed with the Securities and Exchange Commission.
These risk factors include, but are not limited to: changes in the
healthcare industry and regulatory environment; fluctuations in
foreign currency exchange rates; the impact of the Change
Healthcare joint venture on the company’s results of operations;
the company’s ability to manage and complete divestitures and
distributions; material adverse resolution of pending legal
proceedings, including those related to the distribution of
controlled substances; cyberattack, natural disaster, or
malfunction of sophisticated internal computer systems to perform
as designed; and the potential inadequacy of insurance to cover
property loss or liability claims.
About McKesson Corporation
McKesson Corporation is a global leader in healthcare supply
chain management solutions, retail pharmacy, healthcare technology,
community oncology and specialty care. McKesson partners with life
sciences companies, manufacturers, providers, pharmacies,
governments and other healthcare organizations to help provide the
right medicines, medical products and healthcare services to the
right patients at the right time, safely and cost-effectively.
United by our ICARE shared principles, our employees work every day
to innovate and deliver opportunities to improve patient care in
every setting — one product, one partner, one patient at a time.
McKesson has been named a “Most Admired Company” in the healthcare
wholesaler category by FORTUNE, a “Best Place to Work” by the Human
Rights Campaign Foundation, and a top military-friendly company by
Military Friendly. For more information, visit
www.mckesson.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200113005893/en/
Holly Weiss, 972-969-9174 (Investors and Financial Media)
Holly.Weiss@McKesson.com David Matthews, 214-952-0833 (General and
Business Media) David.Matthews@McKesson.com
McKesson (NYSE:MCK)
Historical Stock Chart
From Mar 2024 to Apr 2024
McKesson (NYSE:MCK)
Historical Stock Chart
From Apr 2023 to Apr 2024